Cyclopharm Ltd (CYC) - Total Liabilities

Latest as of December 2025: AU$18.99 Million AUD ≈ $13.44 Million USD

Based on the latest financial reports, Cyclopharm Ltd (CYC) has total liabilities worth AU$18.99 Million AUD (≈ $13.44 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cyclopharm Ltd - Total Liabilities Trend (2005–2025)

This chart illustrates how Cyclopharm Ltd's total liabilities have evolved over time, based on quarterly financial data. See CYC working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Cyclopharm Ltd Competitors by Total Liabilities

The table below lists competitors of Cyclopharm Ltd ranked by their total liabilities.

Company Country Total Liabilities
Unlu Yatirim Holding AS
IS:UNLU
Turkey TL2.35 Billion
Thonburi Medical Centre Public Company Limited
BK:KDH
Thailand ฿197.58 Million
Hilbert Group AB Series B
ST:HILB-B
Sweden Skr232.20 Million
QPM Energy Ltd
AU:QPM
Australia AU$208.69 Million
Sirios Resources Inc.
V:SOI
Canada CA$2.88 Million
Ozerden Plastik Sanayi
IS:OZRDN
Turkey TL52.79 Million
Vinyl Chemicals (India) Limited
NSE:VINYLINDIA
India Rs1.03 Billion
Helixmith Co. Ltd
KQ:084990
Korea ₩1.66 Billion

Liability Composition Analysis (2005–2025)

This chart breaks down Cyclopharm Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Cyclopharm Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.53 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.70 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cyclopharm Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cyclopharm Ltd (2005–2025)

The table below shows the annual total liabilities of Cyclopharm Ltd from 2005 to 2025.

Year Total Liabilities Change
2025-12-31 AU$18.99 Million
≈ $13.44 Million
-2.10%
2024-12-31 AU$19.40 Million
≈ $13.72 Million
+42.05%
2023-12-31 AU$13.65 Million
≈ $9.66 Million
+4.99%
2022-12-31 AU$13.01 Million
≈ $9.20 Million
+2.62%
2021-12-31 AU$12.67 Million
≈ $8.97 Million
+13.57%
2020-12-31 AU$11.16 Million
≈ $7.90 Million
+19.68%
2019-12-31 AU$9.32 Million
≈ $6.60 Million
+43.00%
2018-12-31 AU$6.52 Million
≈ $4.61 Million
+6.41%
2017-12-31 AU$6.13 Million
≈ $4.34 Million
+55.01%
2016-12-31 AU$3.95 Million
≈ $2.80 Million
+14.96%
2015-12-31 AU$3.44 Million
≈ $2.43 Million
+7.29%
2014-12-31 AU$3.21 Million
≈ $2.27 Million
-40.08%
2013-12-31 AU$5.35 Million
≈ $3.78 Million
-11.56%
2012-12-31 AU$6.05 Million
≈ $4.28 Million
-9.58%
2011-12-31 AU$6.69 Million
≈ $4.73 Million
-20.15%
2010-12-31 AU$8.38 Million
≈ $5.93 Million
+46.54%
2009-12-31 AU$5.72 Million
≈ $4.04 Million
+3.47%
2008-12-31 AU$5.52 Million
≈ $3.91 Million
+51.95%
2007-12-31 AU$3.64 Million
≈ $2.57 Million
-62.24%
2006-12-31 AU$9.63 Million
≈ $6.81 Million
-0.29%
2005-12-31 AU$9.66 Million
≈ $6.83 Million
--

About Cyclopharm Ltd

AU:CYC Australia Medical Distribution
Market Cap
$50.40 Million
AU$71.23 Million AUD
Market Cap Rank
#21906 Global
#785 in Australia
Share Price
AU$0.57
Change (1 day)
+0.89%
52-Week Range
AU$0.54 - AU$1.23
All Time High
AU$3.26
About

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribu… Read more